Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 01, 2026
Adragos Pharma announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi.
read more
Wednesday, April 01, 2026
NJ Bio and Ajinomoto Bio Pharma Services announced a research collaboration to expand access to AJICAP™, Aji Bio Pharma's site specific conjugation platform for NJ Bio's discovery stage and early development clients.
read more
Symeres has partnered with Ambagon Therapeutics to explore a new class of small molecules, known as molecular glues, for potential use in colorectal cancer and other hard-to-target diseases.
read more
Bracco Imaging announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced Investments in the site since 2019.
read more
Lumicera Health Services announced the launch of Clarventa, a new company created to address one of the most persistent drivers of rising prescription drug costs: the complex pharmaceutical supply chain.
read more
LabConnect has launched a new digital platform that enables research sites to scan, record, and transmit participant sample data directly from mobile devices.
read more
Torqur AG, a clinical-stage biotechnology company advancing treatments for oncology and dermatology, and Lonza, a contract development and manufacturing organizations\ (CDMOs), announced an agreement for the clinical supply of bimiralisib, an ...
read more
Samsung Biologics announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States.
read more
Experic announced a strategic collaboration with Flurry Powders to bring together complementary expertise to accelerate development of next generation therapies requiring advanced particle engineering.
read more
Southwest Research Institute (SwRI) has opened a new 21,000-square-foot Clinical Supply Facility (CSF) designed to expand its pharmaceutical development and bioengineering capabilities in San Antonio, Texas.
read more
Piramal Pharma Solutions announced the installation of a Korsch X3 high containment tablet press at its integrated API and oral solid development and manufacturing site in Morpeth, UK.
read more
StarLIMS has agreed to acquire the MODA® Platform, a solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.
read more
Perceptive eClinical and Kayentis have announced a strategic alliance to provide a fully integrated electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT) solution for global clinical trials.
read more
Monash University and ClinChoice announced a strategic partnership designed to fast-track early-phase clinical trials and bring groundbreaking health innovations and discoveries closer to patients worldwide.
read more
OFD Life Sciences, a division of Oregon Freeze Dry, has been awarded a patent for its LyoPastille oral delivery platform, an orally dissolving tablet (ODT) technology.
read more